In the original version of this article (1), there are errors in the Methods section. In the subsection titled “NMR and Isothermal Titration Calorimetry,” all mentions of compound 2 have been corrected to compound 6. In addition, the citations of PDB validation reports for MCL1 cocrystal structures throughout the article have been replaced with the corresponding PDB codes. These changes have been made in the latest online HTML and PDF versions of the article. The authors regret these errors.
References
1.
Caenepeel
S
, Brown
SP
, Belmontes
B
, Moody
G
, Keegan
KS
, Chui
D
, et al AMG 176, a selective MCL1 inhibitor, is effective in hematologic cancer models alone and in combination with established therapies
. Cancer Discov
2018
;8
:1582
–97
.©2019 American Association for Cancer Research.
2019
American Association for Cancer Research.